Research Center for Medical Glycoscience, National Institute of Advanced Industrial Science and Technology (AIST), Tsukuba, Ibaraki, Japan.
Appl Environ Microbiol. 2010 Oct;76(19):6351-9. doi: 10.1128/AEM.01026-10. Epub 2010 Aug 6.
The production of selenomethionine (SeMet) derivatives of recombinant proteins allows phase determination by single-wavelength or multiwavelength anomalous dispersion phasing in X-ray crystallography, and this popular approach has permitted the crystal structures of numerous proteins to be determined. Although yeast is an ideal host for the production of large amounts of eukaryotic proteins that require posttranslational modification, the toxic effects of SeMet often interfere with the preparation of protein derivatives containing this compound. We previously isolated a mutant strain (SMR-94) of the methylotrophic yeast Pichia pastoris that is resistant to both SeMet and selenate and demonstrated its applicability for the production of proteins suitable for X-ray crystallographic analysis. However, the molecular basis for resistance to SeMet by the SMR-94 strain remains unclear. Here, we report the characterization of SeMet-resistant mutants of Saccharomyces cerevisiae and the identification of a mutant allele of the MUP1 gene encoding high-affinity methionine permease, which confers SeMet resistance. Although the total methionine uptake by the mup1 mutant (the SRY5-7 strain) decreased to 47% of the wild-type level, it was able to incorporate SeMet into the overexpressed epidermal growth factor peptide with 73% occupancy, indicating the importance of the moderate uptake of SeMet by amino acid permeases other than Mup1p for the alleviation of SeMet toxicity. In addition, under standard culture conditions, the mup1 mutant showed higher productivity of the SeMet derivative relative to other SeMet-resistant mutants. Based on these results, we conclude that the mup1 mutant would be useful for the preparation of selenomethionyl proteins for X-ray crystallography.
硒代蛋氨酸(SeMet)衍生物的重组蛋白的生产允许在 X 射线晶体学中通过单波长或多波长反常散射相位测定来进行相确定,这种流行的方法已经允许许多蛋白质的晶体结构被确定。尽管酵母是生产需要翻译后修饰的大量真核蛋白质的理想宿主,但硒代蛋氨酸的毒性作用经常干扰含有这种化合物的蛋白质衍生物的制备。我们之前分离了一株甲醇营养酵母毕赤酵母(Pichia pastoris)的突变株(SMR-94),它对硒代蛋氨酸和硒酸盐都有抗性,并证明了它在生产适合 X 射线晶体学分析的蛋白质方面的适用性。然而,SMR-94 菌株对硒代蛋氨酸抗性的分子基础仍不清楚。在这里,我们报告了酿酒酵母(Saccharomyces cerevisiae)的硒代蛋氨酸抗性突变体的特征,并鉴定了编码高亲和力蛋氨酸转运蛋白的 MUP1 基因的突变等位基因,该基因赋予了硒代蛋氨酸抗性。尽管 mup1 突变体(SRY5-7 菌株)的总蛋氨酸摄取量下降到野生型水平的 47%,但它能够将硒代蛋氨酸掺入过量表达的表皮生长因子肽中,占据 73%的位置,这表明除了 Mup1p 之外,氨基酸转运蛋白对中等摄取硒代蛋氨酸对于减轻硒代蛋氨酸毒性非常重要。此外,在标准培养条件下,mup1 突变体相对于其他硒代蛋氨酸抗性突变体表现出更高的硒代蛋氨酸衍生物生产力。基于这些结果,我们得出结论,mup1 突变体将有助于制备用于 X 射线晶体学的硒代蛋氨酸蛋白。